Natural Alternatives International, Inc.

Equities

NAII

US6388423021

Pharmaceuticals

Delayed Nasdaq 11:25:34 2024-04-24 am EDT 5-day change 1st Jan Change
6.67 USD +5.21% Intraday chart for Natural Alternatives International, Inc. +2.62% +2.14%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs CI
CarnoSyn®? Brands Partners with Barentz for Exclusive Brazilian Distribution of CarnoSyn®? Beta-Alanine CI
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q2 Revenue $25.2M MT
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q1 Revenue $34M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
North American Morning Briefing : Yield Surge -2- DJ
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q4 Revenue $35.9M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023 CI
North American Morning Briefing : Stock Futures -2- DJ
Natural Alternatives Temporarily Shuts New Facility in California; Staff Furlough Notice Issued; Shares Drop After Hours MT
Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs CI
Natural Alternatives International Appoints Shane Conti as New VP of Global Sales CI
Natural Alternatives International, Inc. Enters into A Fourth Amendment to Lease Amending and Extending the Term of the Lease of Its Vista California Manufacturing Facilities CI
Natural Alternatives International Adds New Manufacturing Unit in California MT
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Reports Q3 Revenue $32.7M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
North American Morning Briefing : Hopes of Easing -2- DJ
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Posts Q2 Revenue $42.3M MT
Tranche Update on Natural Alternatives International, Inc.'s Equity Buyback Plan announced on June 3, 2011. CI
Natural Alternatives International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Natural Alternatives International Inc. announces an Increase in Equity Buyback. CI
Earnings Flash (NAII) NATURAL ALTERNATIVES INTERNATIONAL Posts Q1 Revenue $43.1M MT
Chart Natural Alternatives International, Inc.
More charts
Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through two segments: Private-label contract manufacturing, and Royalty, licensing, and raw material. The Private-label contract manufacturing segment primarily provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. Royalty, licensing, and raw material segment associated with the sale and license of beta-alanine under the Company’s CarnoSyn and SR CarnoSyn trademarks. The Company provides private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements as well as other health care products. It private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
More about the company
  1. Stock Market
  2. Equities
  3. NAII Stock
  4. News Natural Alternatives International, Inc.
  5. Insider Trends: Natural Alternatives International Insider Extends 90-Day Selling Trend